Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
A Financial Times article triggered a Director complaint about Lilly’s 40over40 ED campaign. TV ad was not in breach, but website/leaflet treatment…
Consumers International alleged Lilly’s 40over40 ED campaign promoted Cialis to the public. The Panel applied earlier findings: TV ad not promotional, but…
A competitor challenged Guerbet’s exhibition claim that Dotarem had the “highest Stability”. Although the claim was considered true, the context could imply…
A GP challenged a Lipitor journal ad using a fireman analogy. The Panel and Appeal Board found it misleading for exaggerating urgency…
Actelion challenged Encysive’s Thelin pilot scheme using credit notes for failed treatment. The Panel found an inducement risk and ruled a breach,…
Teva challenged two Trinity-Chiesi clinical support service pharmacist forms implying increased use of Clenil Modulite. The Panel found the complaint was too…
Roche was ruled in breach after Xenical was effectively supplied via a non-health professional at a private clinic and a proposed £55,000…
An anonymous GSK employee challenged a diabetes service partnership with a primary healthcare service company. A voicemail and contract implied funding was…
An anonymous representative alleged pressure to promote Aldara off-licence and raised concerns about call-rate targets and a GP letter. The Panel ruled…
Anonymous complaint alleged Trinity-Chiesi sponsored a switch service to Clenil. Panel reviewed the Clinical Support Service documents and process and found no…
A PCT pharmacist alleged a Clenil cost-comparison chart was misleading because it omitted 200mcg data. The Panel found the Scottish Drug Tariff…
Baxter alleged Johnson & Johnson used the Trasylol (aprotinin) safety alert to promote Quixil in a misleading way. The Panel found briefing…
Two websites promoted unlicensed N-carbamyl-L-glutamic acid and anhydrous betaine powders with therapeutic indications and dosing information. The Panel ruled this amounted to…
A GP complained about an allegedly unsolicited promotional email for Actonel Combi. The Panel found the recipient had given prior, fully informed…
A GP alleged a £250 honorarium plus hospitality and transport to attend a Movicol advisory forum was excessive and a loophole to…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
